J A Thompson1, M C Benyunes, J A Bianco, A Fefer. Show Affiliations » 1. Department of Medicine, University of Washington School of Medicine, Seattle.
Abstract
Entities: Chemical Disease Gene
Mesh: See more » Carcinoma, Renal Cell/secondaryCarcinoma, Renal Cell/therapyCiprofloxacin/administration & dosageCiprofloxacin/therapeutic useClinical Trials as TopicDrug Therapy, CombinationHumansImmunotherapy, Adoptive/methodsInterleukin-2/administration & dosageInterleukin-2/adverse effectsInterleukin-2/therapeutic useKidney Neoplasms/therapyKiller Cells, Lymphokine-ActivatedPentoxifylline/administration & dosagePentoxifylline/therapeutic useRecombinant Proteins/administration & dosageRecombinant Proteins/adverse effectsRecombinant Proteins/therapeutic use
Substances: See more » Interleukin-2Recombinant ProteinsCiprofloxacinPentoxifylline
Year: 1993 PMID: 8284692
Source DB: PubMed Journal: Semin Oncol ISSN: 0093-7754 Impact factor: 4.929